Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome in Spain: Clinical and Genetic Characterization
Ana Beatriz Sánchez‐Heras(Hospital General Universitario de Elche), José Luís Soto(Hospital General Universitario de Elche), Raquel Perea Ibañez(Hospital General Universitario de Elche), Teresa Ramón y Cajal(Hospital de Sant Pau), María Fonfría(Harvard University), Adrià López‐Fernández(Vall d'Hebron Hospital Universitari), Pere Berbel(Universitat de Miguel Hernández d'Elx), Carmen Yagüe(Consorci Sanitari de Terrassa), I. Escandell(Hospital General de Elda), Rosario Sánchez‐Martínez(Hospital General Universitario de Alicante Doctor Balmis), Mercedes Robledo(The University of Texas at San Antonio Health Science Center), Adela Castillejo(Hospital General Universitario de Elche), Gemma Llort(Corporació Sanitària Parc Taulí), Àlex Teulé(Institut d'Investigació Biomédica de Bellvitge), M.I. Castillejo(Hospital General Universitario de Elche), Judith Balmañà(Vall d'Hebron Hospital Universitari), M. Durán(Universidad de Valladolid), Consol López San Martin(Hospital de Sant Pau), Luis Robles(Hospital Universitario 12 De Octubre), Enrique Lastra(Hospital General Yagüe), García Díaz(Hospital Universitario Príncipe de Asturias), Ángel Zúñiga(Hospital Universitari i Politècnic La Fe), L. Gómez Pérez(Hospital Universitari Sant Joan D'Alacant), José María Mesa-Latorre(Hospital Universitario Príncipe de Asturias), Isabel Chirivella(Universitat de València)
Cited by 25
Related Papers
Olaparib Monotherapy in Patients With Advanced Cancer and a Germline <i>BRCA1/2</i> Mutation
|Journal of Clinical Oncology|2014|1.7k
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
|Annals of Oncology|2012|1.5k
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer
|Nature Genetics|2017|565
Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma
|Nature Genetics|2011|528
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer
|Nature Genetics|2017|476